About
We have a clear vision and commitment to build a successful next-generation, technology driven biopharma company making a difference for patients worldwide.
Our Mission
To accelerate the development of life-changing medicines, by investing in science and technology.
Our Vision
To lead the next era of medicine. From Japan, for Japan, and by extension, to the world.
Our Values
Patients, carers, families, and physicians come first
Innovation and teamwork inspire success
Focus on top priorities where we can make a difference
Speed and agility of decision-making
Operational excellence
Company History
Our history since establishment
Click on a year to discover more
Sosei Co. Ltd. established in Bunkyo-ku, Tokyo, with the goal of being a biopharmaceutical R&D and technology transfer business
OUR STRATEGY
Our commercial approach aims to maximize success and provide multiple options to advance our own and externally sourced candidates to patients in Japan and globally:
1
In-house development and commercialization of select wholly owned programs for Japan/APAC
2
Late-stage clinical development and commercialization for in-licensed assets in Japan/APAC
3
Partnering assets with early clinical POC for global commercialization, retaining Japan/APAC rights
Patients Treated
10,300
with PIVLAZ
Delivering Life-Changing Medicines to Patients in Japan
Programs
Progressing High-Value Programs by Design
GPCR structures solved
375+
...and counting